Information about the Coronavirus

Griffin Health is committed to your care and safety. Please call your doctor or provider before your visit. General COVID-19 information is available here. Vaccination information is available here.

Schedule your COVID-19 test at 203-437-6815.

Healthcare-Associated Infections

Healthcare-associated infections (HAIs) are a major public health concern in the United States resulting in 1.7million infections and over 99,000 deaths each year. According to the Centers for Disease Control (CDC), A Healthcare Associated Infection (HAI) is defined as a localized or systemic condition resulting from an adverse reaction to the presence of an infectious agent(s) or its toxin(s) that:

  • a) Occurs in a patient in a healthcare setting
  • b) Was not found to be present or incubating at the time of admission unless the infection was related to a previous admission to the same setting
  • c) If the setting is a hospital, meets the criteria for a specific infection site as defined by the CDC

Hospitals, including Griffin Hospital, routinely practice infection control measures that are put in place to help reduce the risks of infection. Some of the control measures that we use are:

  • Standard and Transmission Based Precautions
  • Use of antimicrobial dressings for specified central lines
  • Total respiratory screening for all patients who undergo an operative procedure
  • High Reliability Clinical Bundles
    • High Reliability Clinical Bundles include specific targeted measures to prevent hospital acquired conditions (HACs) such as:
      • Surgical site infections (SSI): using appropriate use and dosing of antibiotics, maintaining proper body temperature, and time out reviews by the surgical team prior to procedures.
      • Central Line Bundle (CLABSI): hand hygiene, maximal barrier precautions, chlorhexidine skin cleansing, optimal catheter site selection, and daily review of line necessity to prevent central line associated blood stream infections.

We conduct “targeted surveillance” which is data collected for selected infections. The infections that we have targeted are: a) device associated infections: central line associated urinary tract infections; b) surgical site infections (SSIs) for knee arthroplasty, hip arthroplasty, colon surgery, and abdominal hysterectomy; c) Lab identified events including MRSA Bacteremia (Methicillin-resistant Staphylococcus aureus), blood infection and C-Difficile, an intestinal infection.

    FY2015 FY2016 FY2017 FY2018 FY2019 FY2020 FY2021
Central Line Associated Blood Stream Infection Observed Cases: 0 0 0 1 0 2 3
Cather-Associated Urinary Tract Infection Observed Cases: 0 0 1* 3 3 1 2
Surgical Site Infection - Colon Surgery Observed Cases: 0 0 0 1 4 4 1
Surgical Site Infection - Abdominal Hysterectomy Observed Cases: 0 0 0 0 1 1 0
Surgical Site Infection - Total Hip Replacement Observed Cases: 0 0 0 1 1 2 1
Surgical Site Infection - Total Knee Replacement Observed Cases: 0 0 1 0 0 1 0
MRSA Blood Infections    Observed Cases Observed Cases: 1 2 1 2 2 6 4
Clostridium difficile (C.diff) Intestinal Infection Observed Cases: 4 13 10 7 12 7 13


* Definition changed to include ICU and other select hospital units, previously included only ICU